Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis Journal Article


Authors: McDonald, O. G.; Li, X.; Saunders, T.; Tryggvadottir, R.; Mentch, S. J.; Warmoes, M. O.; Word, A. E.; Carrer, A.; Salz, T. H.; Natsume, S.; Stauffer, K. M.; Makohon-Moore, A.; Zhong, Y.; Wu, H.; Wellen, K. E.; Locasale, J. W.; Iacobuzio-Donahue, C. A.; Feinberg, A. P.
Article Title: Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
Abstract: During the progression of pancreatic ductal adenocarcinoma (PDAC), heterogeneous subclonal populations emerge that drive primary tumor growth, regional spread, distant metastasis, and patient death. However, the genetics of metastases largely reflects that of the primary tumor in untreated patients, and PDAC driver mutations are shared by all subclones. This raises the possibility that an epigenetic process might operate during metastasis. Here we report large-scale reprogramming of chromatin modifications during the natural evolution of distant metastasis. Changes were targeted to thousands of large chromatin domains across the genome that collectively specified malignant traits, including euchromatin and large organized chromatin histone H3 lysine 9 (H3K9)-modified (LOCK) heterochromatin. Remarkably, distant metastases co-evolved a dependence on the oxidative branch of the pentose phosphate pathway (oxPPP), and oxPPP inhibition selectively reversed reprogrammed chromatin, malignant gene expression programs, and tumorigenesis. These findings suggest a model whereby linked metabolic epigenetic programs are selected for enhanced tumorigenic fitness during the evolution of distant metastasis.
Keywords: methylation; adenocarcinoma; dynamics; embryonic stem-cells; growth; domains; histone acetylation; blocks; 6-aminonicotinamide
Journal Title: Nature Genetics
Volume: 49
Issue: 3
ISSN: 1061-4036
Publisher: Nature Publishing Group  
Date Published: 2017-03-01
Start Page: 367
End Page: 376.e2
Language: English
ACCESSION: WOS:000394917800010
DOI: 10.1038/ng.3753
PROVIDER: wos
PUBMED: 28092686
PMCID: PMC5695682
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yi Zhong
    15 Zhong